Open AccessSignificance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients
Author(s) -
Cecelia Miller,
Ying Huang,
Amy S. Ruppert,
Jadwiga Labanowska,
Samantha Jaglowski,
Kami J. Maddocks,
Kerry A. Rogers,
Seema A. Bhat,
Adam S. Kittai,
Michael R. Grever,
Rosa Lapalombella,
Lynne V. Abruzzo,
Nyla A. Heerema,
John C. Byrd,
Erin Hertlein,
Jennifer A. Woyach
Publication year - 2021
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-021-01237-x
Subject(s) - ibrutinib , chronic lymphocytic leukemia , leukemia , medicine , oncology , philadelphia chromosome , cancer research , biology , genetics , chromosomal translocation , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom